XNAS
KDLYW
Market cap72mUSD
May 22, Last price
18.65USD
Name
Kindly MD Inc
Chart & Performance
P/E
—
P/S
41.29
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
3m
-27.83%
Net income
-4m
L+123.66%
CFO
-3m
L+583.86%
Profile
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | ||||
Revenues | 2,720 -27.83% | 3,769 -0.49% | 3,787 51.22% | |
Cost of revenue | 2,368 | 5,283 | 6,480 | |
Unusual Expense (Income) | ||||
NOPBT | 352 | (1,515) | (2,693) | |
NOPBT Margin | 12.95% | |||
Operating Taxes | 5 | |||
Tax Rate | ||||
NOPAT | 352 | (1,515) | (2,693) | |
Net income | (3,618) 123.66% | (1,617) -36.34% | (2,541) -1,801.26% | |
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 5,861 | 400 | ||
BB yield | -87.66% | |||
| Debt | ||||
Debt current | 280 | 243 | 153 | |
Long-term debt | 1,148 | 652 | 476 | |
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | (846) | 370 | 442 | |
| Cash flow | ||||
Cash from operating activities | (3,074) | (449) | (140) | |
CAPEX | (13) | (14) | (317) | |
Cash from investing activities | (402) | (14) | (317) | |
Cash from financing activities | 5,224 | 802 | 550 | |
FCF | 59 | (1,363) | (3,035) | |
| Balance | ||||
Cash | 2,274 | 526 | 187 | |
Long term investments | ||||
Excess cash | 2,138 | 337 | ||
Stockholders' equity | (7,770) | (4,153) | (2,536) | |
Invested Capital | 11,122 | 4,681 | 3,308 | |
ROIC | 4.46% | |||
ROCE | 10.51% | |||
| EV | ||||
Common stock shares outstanding | 5,391 | 5,971 | 5,971 | |
Price | 1.24 | |||
Market cap | 6,685 | |||
EV | 5,840 | |||
EBITDA | 573 | (1,311) | (2,571) | |
EV/EBITDA | 10.20 | |||
Interest | 393 | 56 | ||
Interest/NOPBT | 111.70% | |||